Literature DB >> 18080083

Regulation of cell-matrix contacts and beta-catenin signaling in VSMC by integrin-linked kinase: implications for intimal thickening.

Amrita Dwivedi1, Graciela B Sala-Newby, Sarah Jane George.   

Abstract

Vascular smooth muscle cell (VSMC) proliferation and migration is responsible for intimal thickening that occurs in restenosis and atherosclerosis. Integrin-linked kinase (ILK) is a serine/threonine protein kinase implicated in signaling pathways involved in cell proliferation and migration. We studied the involvement of ILK in intimal thickening. ILK expression was significantly increased in two models of intimal thickening: balloon-injured rat carotid arteries and human saphenous vein organ cultures. Over-expression of a dominant negative ILK (DN-ILK) significantly reduced intimal thickening by approximately 50% in human saphenous vein organ cultures, demonstrating an important role in intimal thickening. ILK protein and activity was reduced on laminin and up-regulated on fibronectin, indicating ILK protein expression is modulated by extracellular matrix composition. Inhibition of ILK by siRNA knockdown and DN-ILK significantly decreased VSMC proliferation and migration while wild type ILK significantly increased proliferation and migration on laminin, confirming an essential role of ILK in both processes. Localization of paxillin and vinculin and protein levels of FAK and phospho-FAK indicated that inhibition of ILK reduced focal adhesion formation. Additionally, inhibition of ILK significantly attenuated the presence of the cell-cell complex proteins N-cadherin and beta-catenin, and beta-catenin signaling. We therefore suggest ILK modulates VSMC proliferation and migration at least in part by acting as a molecular scaffold in focal adhesions as well as modulating the stability of cell-cell contact proteins and beta-catenin signaling. In summary, ILK plays an important role in intimal thickening by modulating VSMC proliferation and migration via regulation of cell-matrix and cell-cell contacts and beta-catenin signaling.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18080083      PMCID: PMC2853711          DOI: 10.1007/s00395-007-0693-9

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  41 in total

1.  Wild-type p53 gene transfer inhibits neointima formation in human saphenous vein by modulation of smooth muscle cell migration and induction of apoptosis.

Authors:  S J George; G D Angelini; M C Capogrossi; A H Baker
Journal:  Gene Ther       Date:  2001-05       Impact factor: 5.250

2.  Regulation of protein kinase B/Akt-serine 473 phosphorylation by integrin-linked kinase: critical roles for kinase activity and amino acids arginine 211 and serine 343.

Authors:  S Persad; S Attwell; V Gray; N Mawji; J T Deng; D Leung; J Yan; J Sanghera; M P Walsh; S Dedhar
Journal:  J Biol Chem       Date:  2001-04-19       Impact factor: 5.157

3.  Selective expression of an endogenous inhibitor of FAK regulates proliferation and migration of vascular smooth muscle cells.

Authors:  J M Taylor; C P Mack; K Nolan; C P Regan; G K Owens; J T Parsons
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

4.  Integrin-linked kinase (ILK) binding to paxillin LD1 motif regulates ILK localization to focal adhesions.

Authors:  S N Nikolopoulos; C E Turner
Journal:  J Biol Chem       Date:  2001-04-13       Impact factor: 5.157

5.  Control of smooth muscle cell proliferation and phenotype by integrin signaling through focal adhesion kinase.

Authors:  A O Morla; J E Mogford
Journal:  Biochem Biophys Res Commun       Date:  2000-05-27       Impact factor: 3.575

6.  Molecular dissection of actopaxin-integrin-linked kinase-Paxillin interactions and their role in subcellular localization.

Authors:  Sotiris N Nikolopoulos; Christopher E Turner
Journal:  J Biol Chem       Date:  2001-11-01       Impact factor: 5.157

7.  A role for the beta-catenin/T-cell factor signaling cascade in vascular remodeling.

Authors:  Xiaohong Wang; Yan Xiao; Yongshan Mou; Ying Zhao; W Matthijs Blankesteijn; Jennifer L Hall
Journal:  Circ Res       Date:  2002-02-22       Impact factor: 17.367

Review 8.  ILK, PINCH and parvin: the tIPP of integrin signalling.

Authors:  Kyle R Legate; Eloi Montañez; Oliver Kudlacek; Reinhard Fässler
Journal:  Nat Rev Mol Cell Biol       Date:  2006-01       Impact factor: 94.444

9.  A novel integrin-linked kinase-binding protein, affixin, is involved in the early stage of cell-substrate interaction.

Authors:  S Yamaji; A Suzuki; Y Sugiyama; Y Koide ; M Yoshida; H Kanamori; H Mohri; S Ohno; Y Ishigatsubo
Journal:  J Cell Biol       Date:  2001-06-11       Impact factor: 10.539

10.  Drosophila integrin-linked kinase is required at sites of integrin adhesion to link the cytoskeleton to the plasma membrane.

Authors:  C G Zervas; S L Gregory; N H Brown
Journal:  J Cell Biol       Date:  2001-03-05       Impact factor: 10.539

View more
  11 in total

1.  N-Cadherin, a novel and rapidly remodelling site involved in vasoregulation of small cerebral arteries.

Authors:  Zhe Sun; Min Li; Zhaohui Li; Michael A Hill; Gerald A Meininger
Journal:  J Physiol       Date:  2017-02-07       Impact factor: 5.182

2.  CTGF disrupts alveolarization and induces pulmonary hypertension in neonatal mice: implication in the pathogenesis of severe bronchopulmonary dysplasia.

Authors:  Shaoyi Chen; Min Rong; Astrid Platteau; Dorothy Hehre; Heather Smith; Philip Ruiz; Jeffrey Whitsett; Eduardo Bancalari; Shu Wu
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-01-14       Impact factor: 5.464

3.  ß-Catenin is markedly induced in a murine model of an arteriovenous fistula: the effect of metalloproteinase inhibition.

Authors:  Karl A Nath; Joseph P Grande; Lu Kang; Julio P Juncos; Allan W Ackerman; Anthony J Croatt; Zvonimir S Katusic
Journal:  Am J Physiol Renal Physiol       Date:  2010-09-29

4.  Integrin-linked kinase functions as a downstream signal of platelet-derived growth factor to regulate actin polymerization and vascular smooth muscle cell migration.

Authors:  Mitra Esfandiarei; Sahar Abdoli Yazdi; Virginia Gray; Shoukat Dedhar; Cornelis van Breemen
Journal:  BMC Cell Biol       Date:  2010-02-23       Impact factor: 4.241

5.  Integrin-linked kinase in the vascular smooth muscle cell response to injury.

Authors:  Bernard Ho; Guangpei Hou; J Geoffrey Pickering; Gregory Hannigan; B Lowell Langille; Michelle P Bendeck
Journal:  Am J Pathol       Date:  2008-06-05       Impact factor: 4.307

Review 6.  Integrin linked kinase (ILK) expression and function in vascular smooth muscle cells.

Authors:  Bernard Ho; Michelle P Bendeck
Journal:  Cell Adh Migr       Date:  2009-04-10       Impact factor: 3.405

7.  Modulation of microvascular smooth muscle adhesion and mechanotransduction by integrin-linked kinase.

Authors:  Shaoxing Huang; Zhe Sun; Zhaohui Li; Luis A Martinez-Lemus; Gerald A Meininger
Journal:  Microcirculation       Date:  2010-02       Impact factor: 2.628

8.  BMP promotes motility and represses growth of smooth muscle cells by activation of tandem Wnt pathways.

Authors:  Vinicio A de Jesus Perez; Ziad Ali; Tero-Pekka Alastalo; Fumiaki Ikeno; Hirofumi Sawada; Ying-Ju Lai; Thomas Kleisli; Edda Spiekerkoetter; Xiumei Qu; Laura H Rubinos; Euan Ashley; Manuel Amieva; Shoukat Dedhar; Marlene Rabinovitch
Journal:  J Cell Biol       Date:  2011-01-10       Impact factor: 10.539

9.  Targeting Wnt/β-Catenin Activated Cells with Dominant-Negative N-cadherin to Reduce Neointima Formation.

Authors:  Sarah Hulin-Curtis; Helen Williams; Kerry S Wadey; Graciela B Sala-Newby; Sarah J George
Journal:  Mol Ther Methods Clin Dev       Date:  2017-05-04       Impact factor: 6.698

10.  Advanced glycation end products impair the functions of saphenous vein but not thoracic artery smooth muscle cells through RAGE/MAPK signalling pathway in diabetes.

Authors:  Yongxin Sun; Le Kang; Jun Li; Huan Liu; Yulin Wang; Chunsheng Wang; Yunzeng Zou
Journal:  J Cell Mol Med       Date:  2016-06-14       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.